Answers are grounded in this paper and cite their sources.
PURPOSE OF REVIEW: To discuss issues that affect development of new glaucoma treatments known as neuroprotection. RECENT FINDINGS: There are barriers to neuroprotection trials for glaucoma. SUMMARY: With design features discussed in the review, neuroprotection trials can be effectively carried out.
No takes yet. Share an insight, caveat, or question.
Harry A. Quigley (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: